XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Wealth building strategies vary by income level. Discover tailored approaches that align with your financial circumstances for better results.
23,622 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Winter demand and a growing data-center footprint push grid strain. The Trump administration accelerates a coal reviv...
Investors are buzzing about forum energy technologies stock as Q4 results point to improving demand in energy equipme...
Today’s gain in Viking Therapeutics stock more has traders buzzing, but the move isn’t tied to a single headline. Thi...
A standout earnings beat pushed Clear Secure stock higher on Wednesday as revenue, user growth, and guidance surprise...
Navan stock down from its IPO price has dropped sharply, but a major investor just built a substantial stake. Here’s ...
The Pentagon has begun using low-cost drones modeled after Iran’s Shahed systems in recent strikes, raising questions...
Bybit reports a landmark security win, reclaiming $300 million for thousands of users through AI-powered fraud detect...
Regulatory tightening is reshaping crypto’s path. Barabash argues the most regulated platforms may become the biggest...
Axel Springer has agreed to acquire Telegraph Media Group for £575 million ($766 million), ending a years-long sale s...
Investors are weighing bloom energy stock: buy options as the company scales its solid oxide fuel cells for AI data c...
Earnings calls reveal the health of specialized housing providers. This guide breaks down how to interpret target hos...